Matches 1 - 50 out of 262 1 2 3 4 5 6 >


Match Document Document Title
US20140121191 Oral Energy Supplement and Related Methods  
The present invention relates to oral dosage formulations consisting of at least one active ingredient contained in a plurality of hydrophobic carriers dispersed in an aqueous medium comprising a...
US20130136700 POLY-HAPTEN WITH TOPICAL HORMONE ALOPECIA HAIR REGROWTH SYSTEM  
A hair regrowth system consisting of sensitization, growth, and maintenance kits for alopecia areata and related alopecia balding conditions. Graduated doses of specific engineered and or...
US20120225144 Herbal Supplement Prepared From Geranium  
An extraction method for extracts of Geranium or Pelargonium with improved methylhexaneamine content is provided. The method involves separating the oil phase from the aqueous phase; concentrating...
US20150011570 TRANSDERMAL DELIVERY OF BENEFICIAL SUBSTANCES EFFECTED BY A HOSTILE BIOPHYSICAL ENVIRONMENT  
The present invention generally relates to the transdermal delivery of substances and, in some embodiments, to the transdermal delivery of beneficial substances by a hostile biophysical...
US20130197015 NOVEL METHOD TO IMPROVE THE SAFETY AND EFFICACY OF CAFFEINE  
The present invention relates to methods and compositions for reducing side effects associated with caffeine consumption. The methods comprise administering a Receptor Switcher, such as N-acetyl...
US20140200230 COMPOSITIONS AND METHODS FOR INHIBITING REDOX-SENSITIVE GTPASES  
The invention provides compositions for inhibiting a redox-sensitive GTPase protein, including a Rho or Rab family GTPase, comprising an effective amount of a redox-sensitive purine compound and...
US20120171302 COMPOSITIONS AND METHODS FOR INHIBITING REDOX-SENSITIVE GTPASES  
The invention provides compositions for inhibiting a redox-sensitive GTPase protein, including a Rho or Rab family GTPase, comprising an effective amount of a redox-sensitive purine compound and...
US20120111324 Dry Powder Drug Delivery Formulations, Methods of Use, and Devices Therefore  
The present disclosure relates to systems, methods, and formulations for the pulmonary administration of one or more therapeutic agents, in dry powder form, in a single, large dose quantity. These...
US20110086138 Bitter Alkaloid Containing Consumables Comprising Bitter Blockers  
Disclosed are bitter alkaloid-containing consumables comprising bitter blockers for a reduced alkaloid-derived bitterness and methods of forming said consumables.
US20120237570 METHODS AND COMPOSITIONS FOR TREATING DISTRESS DYSFUNCTION AND ENHANCING SAFETY AND EFFICACY OF SPECIFIC MEDICATIONS  
The present invention relates to methods and compositions for reducing distress dysfunction, including emotional and physical distress. The invention entails co-administration of at least one...
US20110195425 SYSTEMS AND METHODS FOR DIAGNOSING PARASITE INFECTIONS  
Systems and methods for diagnosing parasite infections. According to at least one embodiment of a stabilizing system of the present disclosure, a stabilizing system comprises a stabilizing agent...
US20110245323 RIG-Like Helicase Innate Immunity Inhibits VEGF-Induced Tissue Responses  
The present invention encompasses compositions and compounds as well as methods of their use for the regulation of a VEGF-induced tissue response. A VEGF-induced tissue response may include...
US20130090307 BACLOFEN AND ACAMPROSATE BASED THERAPY OF NEUROLOGICAL DISORDERS  
The present invention relates to combinations and methods for the treatment of neurological disorders related to glutamate excitotoxicity and Amyloid β toxicity. More specifically, the present...
US20120083473 TREATMENT OF CONDITIONS BY TOLL-LIKE RECEPTOR MODULATORS  
Provided herein are methods for treating certain conditions, including fibrosis, inflammatory, and autoimmune conditions, with conjugated compounds having Toll-like receptor modulatory activity.
US20120277179 Edible Energy Composition  
The disclosure relates to an edible energy composition that provides physical and mental benefits when ingested.
US20130324563 METHOD OF INTENSIFYING THE PHYSIOLOGICAL ACTION OF CAFFEINE  
It is an object of the present invention to provide: a method for safely and effectively enhancing the physiological action of caffeine even from a low intake of caffeine, when utilized various...
US20110275561 Treatment for diabetes in patients with insufficient glycemic control despite therapy with an oral or non-oral antidiabetic drug  
The present invention relates to the finding that certain DPP-4 inhibitors are particularly suitable for treating and/or preventing metabolic diseases, particularly diabetes, in patients with...
US20140335074 METHODS FOR IMPROVING MEDICAL THERAPIES  
Methods are provided herein for enhancing the effectiveness of medical therapies by administering agents that suppress a biological damage response that is inducible by the medical therapy...
US20130045162 DELIVERY SYSTEM FOR SPECIFICALLY TARGETING CANCER CELLS AND METHOD OF USE THEREOF  
Methods for prevention, treatment or inhibition of the growth or metastasis of cancer cells in a subject are disclosed. One method comprises the step of administering to the subject a...
US20130029989 TOPICAL TREATMENTS FOR PAIN  
The present invention relates to novel compositions and therapeutic methods for the treatment of pain, in particular neuropathic, ischemic, muscle, arthritic or multiple sclerosis pain. The...
US20120053142 COMPOSITIONS AND METHODS FOR MINIMIZING AND/OR REDUCING THE APPEARANCE OF DEFECTS AROUND EYES  
The invention relates to compositions comprising at least one xanthine compound, preferably further comprising at least one agent which acts on capillary circulation and/or at least one natural...
US20110020471 ERYTHROCYTE ATP-RELEASE MODULATORS  
Erythrocyte ATP-release modulators and composition and methods for their use to potentiate serum glucose clearance and vasodilation; methods for prophylactic or palliative therapy of glucose...
US20110269717 NEUROGENESIS BY MODULATING ANGIOTENSIN  
The instant invention describes methods for treating diseases and conditions of the central and peripheral nervous system by stimulating or increasing neurogenesis. The invention includes...
US20150132280 THEACRINE-BASED SUPPLEMENT AND METHOD OF USE THEREOF  
A human dietary supplement comprises theacrine and optionally other compounds that modulate the effects of theacrine. Uses for the theacrine-containing supplement include improvement of at least...
US20110104083 METHODS AND COSMETIC PREPARATIONS FOR THE SUSTAINED DELIVERY OF THERAPEUTIC AGENTS TO THE EYE  
Cosmetic compositions comprising therapeutic agents for the treatment of various eye conditions and methods of use are described. In particular, the invention provides cosmetic compositions...
US20060258561 Novel NPH insulin preparations  
This invention relates to NPH-insulin (crystalline preparations) that are prepared in the presence of certain high-affinity ligands for the HisB10 Zn2+-sites of the R-state insulin hexamer....
US20110195397 DRINK MIXTURE FOR THE STABILIZATION OF DIAGNOSTIC BIOMARKERS  
Drink mixture for the stabilization of diagnostic biomarkers. In at least one embodiment of an ingestible beverage useful to stabilize a diagnostic marker, the rinse comprises a stabilizing agent...
US20120088773 Circadian rhythm modulation  
A method and composition is herein described to modulate the circadian rhythm to effect summer metabolism and the metabolic syndrome. The method entails the once daily, timed ingestion of a...
US20110189275 PTEROSTILBENE COCRYSTALS  
Cocrystals of pterostilbene are disclosed, including: pterostilbene:caffeine cocrystal, pterostilbene:carbamazepine cocrystal, pterostilbene:glutaric acid cocrystal, and pterostilbene:piperazine...
US20150258197 EUTECTIC ISOMETHEPTENE MUCATE  
The present invention relates to pharmaceutical compositions and methods of manufacturing the same, comprising a eutectic of racemic isometheptene mucate and mannitol or (R)-isometheptene mucate...
US20070059360 WATER-DISPERSIBLE ANTI-RETROVIRAL PHARMACEUTICAL COMPOSITIONS  
Provided herein are water-dispersible pharmaceutical compositions comprising a combination of one or more anti-retroviral drugs useful for the treatment of Human Immunodeficiency Virus (HIV)...
US20150250761 COMPOSITIONS AND METHODS FOR TREATMENT OF CHRONIC FATIGUE  
Pharmaceutical compositions and methods for the treatment of chronic fatigue in human patients comprising a central nervous system (CNS) stimulant in a daily low-dosage amount in combination with...
US20120328695 COMPOSITIONS AND METHODS FOR TREATMENT OF CHRONIC FATIGUE  
Pharmaceutical compositions and methods for the treatment of chronic fatigue in human patients comprising a central nervous system (CNS) stimulant in a daily low-dosage amount in combination with...
US20100256169 ADMINISTRATION OF TLR7 LIGANDS AND PRODRUGS THEREOF FOR TREATMENT OF INFECTION BY HEPATITIS C VIRUS  
This invention relates to methods for treating or preventing hepatitis C virus infections in mammals using Toll-Like Receptor (TLR)7 ligands and prodrugs thereof. More particularly, this invention...
US20130150382 NOVEL PHARMACEUTICAL DOSAGE FORMS COMPRISING VALGANCICLOVIR HYDROCHLORIDE  
The present invention provides novel solid pharmaceutical dosage forms for oral administration, after being constituted in water. The solid dosage forms comprise a therapeutically effective amount...
US20140274939 COMBINED SYSTEMIC AND TOPICAL TREATMENT OF DISORDERED TISSUES  
Kits and methods for treating disordered tissue caused by a virus in a mammal involve co-administration of a systemic anti-virus drug and topically administering an anti-infective composition. The...
US20150030668 LIPOSOMALLY ENCAPSULATED REDUCED GLUTATHIONE FOR MANAGEMENT OF CANCER, INCLUDING WITH OTHER PHARMACEUTICAL COMPOSITIONS  
This invention proposes an agent to block the “fuel supply” that energizes cancer cell growth by protecting surrounding cells to the cancer, particularly stromal fibroblast cells. The invention...
US20110123651 DIETARY SUPPLEMENT DRINK FOR DELIVERY OF RESVERATROL AND OTHER POLYPHENOLS  
A nutritional beverage or drink is provided having resveratrol mixed with water, suspended in a liquid suspension system. One or more of quercetin, catechins, antioxidants, energy agents,...
US20070032558 Method of treating herpes viral infections using a halogenated hydrocarbon composition  
A method to reduce the incidence and time to healing of paraesthesia and skin lesions associated with herpes virus infections. In one form, the method of treatment involves topical application...
US20130251790 Low Dose Pharmaceutical Composition Comprising Zanamivir  
The present invention provides a pharmaceutical composition comprising a low dose of zanamivir and a process for preparing the pharmaceutical composition comprising a low dose of zanamivir. The...
US20050008712 Compositions incorporating high-caffeine green tea extract and related methods for promoting healthy body weight  
Methods for promoting healthy body weight, increasing energy level and improving a variety of related physiological factors include administering to those persons or other mammals effective...
US20140220120 CRYSTAL ENTECAVIR, CRYSTAL ENTECAVIR FORMULATION AND METHODS FOR THE PREPARATION THEREOF  
The present invention relates to a pharmaceutical composition for treating hepatitis B virus infection comprising crystalline entecavir as the pharmaceutically active ingredient and one or more...
US20130012470 ANTIVIRAL COMPOSITIONS AND METHODS OF THEIR USE  
Novel compositions comprising viral fusion inhibition compounds and viral replication inhibition compounds as well as methods of their use are disclosed. The novel compositions are useful, inter...
US20070178099 Suppression of TNFalpha and IL-12 in therapy  
Methods for treating and/or preventing a TNF-mediated disease in an individual are disclosed. Also disclosed are compositions comprising a TNF antagonist and an IL-12 antagonist. TNF-mediated...
US20150196521 PHARMACEUTICAL COMPOSITIONS COMPRISING 15-HEPE AND METHODS OF TREATING ASTHMA AND LUNG DISORDERS USING SAME  
The disclosure provides compositions comprising 15-HEPE or derivatives thereof used singly or in combination with other active agents for the treatment and/or prevention of lung diseases and...
US20050148521 Anti-cancer combination and use thereof  
The present invention relates to the surprising discovery that the combination of several agents, each well known for its established role in treating cancer, inflammation, hemostasis, bone...
US20110195403 SYSTEMS AND METHODS FOR FERTILITY ANALYSIS  
Systems and methods for fertility analysis. In at least one embodiment of a system of the present disclosure, the system comprises a stabilizing agent useful to completely or substantially prevent...
US20090047328 CAFFEINE DELIVERY SYSTEMS  
Described are caffeine-based delivery vehicles. A first delivery vehicle is a malleable strip that dissolves in an oral cavity. Buccal absorption provides a prompt mental and physical stimulation...
US20080268038 Compositions and Approaches for Increasing Diet Induced Thermogenesis, Inducing Weight Loss and Maintaining Muscle Mass and Strength  
Provided are compositions and methods for increasing diet induced thermogenesis. Typically, the compositions are comprised of L-histidine, L-isoleucine, L-leucine, L-lysine, L-methionine,...
US20130236401 PROCESS FOR THE PREPARATION OF INVERSE LATEX OF ACRYLAMIDE-BASED POLYMERS AND COMPOSITION COMPRISING SAID LATEX  
Process for the preparation of a composition including an oil phase, an aqueous phase, at least one emulsifying system of water-in-oil (W/O) type, optionally at least one emulsifying system of...

Matches 1 - 50 out of 262 1 2 3 4 5 6 >